MyETF.app
HomeUS Marketequity › ARKG

ARKG — ARK Genomic Revolution ETF

ARK Genomic Revolution ETF (ticker: ARKG) is a equity ETF issued by ARK Invest LLC tracking ACTIVE - No Index. It was launched on 2014-10-31.

Live Price$36.27
Change6.93%
AUM$1.27B
Expense Ratio0.01%
Avg Volume2,669,471.15

Returns (Total Return)

PeriodReturn
1 Day-0.24%
1 Week5.80%
1 Month11.95%
3 Months16.68%
6 Months10.02%
YTD17.09%
1 Year53.35%
3 Years2.02%
5 Years-56.89%
10 Years
Since Inception

Top Holdings

#SecuritySymbolWeight
1 TEMPUS AI INC TEM 11.73%
2 TEMPUS AI INC TEM 11.73%
3 TEMPUS AI INC TEM 11.73%
4 TEMPUS AI INC TEM 11.73%
5 TEMPUS AI INC TEM 11.73%
6 TEMPUS AI INC TEM 10.90%
7 TEMPUS AI INC TEM 10.90%
8 TEMPUS AI INC TEM 10.90%
9 TEMPUS AI INC TEM 10.90%
10 TEMPUS AI INC TEM 10.90%

Fund Profile

IssuerARK Invest LLC
BrandARK
Asset Classequity
StrategyActive
StructureETF
CategoryHealth & Biotech Equities
SegmentEquity: Global Genomic Advancements
SectorBiotechnology
RegionNorth America
Index TrackedACTIVE - No Index
Inception Date2014-10-31
Tax on DistributionsQualified dividends

Quick Facts

TickerARKG
Full NameARK Genomic Revolution ETF
IssuerARK Invest LLC
Asset Classequity
Expense Ratio0.01%
AUM$1.27B
Inception2014-10-31
Index TrackedACTIVE - No Index

Frequently Asked Questions

What does ARKG track?

ARKG (ARK Genomic Revolution ETF) tracks ACTIVE - No Index, a equity benchmark.

What is the expense ratio of ARKG?

ARKG has an expense ratio of 0.01% per year.

What is the AUM of ARKG?

ARKG has approximately $1.27B in assets under management.

Does ARKG pay a dividend?

ARKG distributes income according to its prospectus (Qualified dividends tax treatment). Check the dividend history tab for ex-dividend dates and yield.

Who issues ARKG?

ARKG is issued by ARK Invest LLC under the ARK brand, launched on 2014-10-31.

Open the interactive ARKG dashboard for charts, historical fund flows, holdings breakdown and seasonality patterns.